Table 5.
FFAs levels in relation with cardiovascular events in patients with different glucose metabolism status
| FFAs | HR (95% CI) | ||
|---|---|---|---|
| Events/subjects 608/5433 | Crude Model | Adjusted Model | |
| NGR | |||
| Low FFAs | 15/268 | Ref | Ref |
| Medium FFAs | 51/553 | 1.665 (0.936–2.962) | 1.543 (0.865–2.752) |
| High FFAs | 23/218 | 1.925 (1.004–3.689)* | 1.856 (0.968–3.559) |
| Pre-DM | |||
| Low FFAs | 61/747 | 1.457 (0.828–2.563) | 1.271 (0.721–2.242) |
| Medium FFAs | 154/1430 | 1.936 (1.140–3.290)* | 1.736 (1.018–2.959)* |
| High FFAs | 70/611 | 2.098 (1.201–3.664)* | 1.779 (1.012–3.126)* |
| DM | |||
| Low FFAs | 32/259 | 2.245 (1.216–4.145)* | 1.937 (1.044–3.594)* |
| Medium FFAs | 96/740 | 2.354 (1.366–4.056)* | 2.017 (1.164–3.494)* |
| High FFAs | 106/607 | 3.308 (1.926–5.680)* | 2.795 (1.619–4.824)* |
Univariate and multivariate Cox proportional hazards regression analysis was performed in crude and adjusted models respectively
Model adjusted for age, sex, body mass index, smoking, hypertension, family history of coronary artery disease, Gensini score, left ventricular ejection fraction, low density lipoprotein cholesterol, high lipoprotein cholesterol, triglyceride, and baseline statin
Model adjusted for age, sex, body mass index, smoking, hypertension, family history of coronary artery disease, Gensini score, left ventricular ejection fraction, low density lipoprotein cholesterol, high lipoprotein cholesterol, triglyceride, and baseline statin
* For p-value < 0.05